Cargando…
Glutamic Acid Increased Methotrexate Polyglutamation and Cytotoxicity in a CCRF-SB Acute Lymphoblastic Leukemia Cell Line
Background and Objectives: Acute lymphoblastic leukemia (ALL) is the most common type of cancer in childhood. The majority of patients respond to treatment, but those with resistant phenotypes suffer relapse or death. The antifolate methotrexate (MTX) is the most commonly used drug against ALL due t...
Autores principales: | Mendoza-Santiago, Alma, Becerra, Edgardo, Garay, Edith, Bah, Moustapha, Berumen-Segura, Laura, Escobar-Cabrera, Jesica, Hernández-Pérez, Abigail, García-Alcocer, Guadalupe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956105/ https://www.ncbi.nlm.nih.gov/pubmed/31779260 http://dx.doi.org/10.3390/medicina55120758 |
Ejemplares similares
-
Specific MRP4 Inhibitor Ceefourin-1 Enhances Apoptosis Induced by 6-Mercaptopurine in Jurkat Leukemic Cells, but Not in Normal Lymphoblast Cell Line CRL-1991
por: Becerra, Edgardo, et al.
Publicado: (2022) -
Methotrexate Polyglutamation in a Myasthenia Gravis Clinical Trial
por: Pasnoor, Mamatha, et al.
Publicado: (2020) -
Differing contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanercept
por: Dervieux, Thierry, et al.
Publicado: (2019) -
A meta‐analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis
por: van de Meeberg, Maartje M., et al.
Publicado: (2022) -
Short-chain methotrexate polyglutamate MTXPG2 as outcome parameter in rheumatoid arthritis
por: Hobl, Eva-Luise, et al.
Publicado: (2010)